LINDBLAD EXPEDITIONS HOLDINGS, INC. Key Metrics

3 years of history · ending 2025-12-31 · SEC EDGAR

Forensics

Three classic accounting-quality scores. F-Score (0-9, higher = better fundamentals); M-Score (>-1.78 flags possible manipulation); Z-Score (>2.99 = safe, <1.81 = distressed). Use together — single-score readings are noisy.

F-Score (Piotroski 0-9)

Z-Score (Altman; <1.81 = distress)

Per Share Metrics

Turnover & Efficiency Analysis (days)

Expense Ratios

Working Capital Analysis

Valuation Multiples

Cash-Flow Multiples

Enterprise Value Multiples

52-Week Range

Trailing Returns

ROIC vs WACC

Yields

Capital Deployment Yields

Liquidity & Leverage Ratios

Earnings Quality (OCF/NI · FCF/NI · Sloan Accruals)

EPS (Diluted)
$-1
Book Value Per Share
$-5
Free Cash Flow Per Share
$1
Cash Per Share
$5
Revenue Per Share
$14
OCF Per Share
$2
Return on Equity
11.1%
Return on Assets
-3.2%
Return on Invested Capital
9.6%
Debt to Equity
-2.33
Current Ratio
0.80
Quick Ratio
0.80
Asset Turnover
0.83
Days Payables Outstanding
19.41
Days Inventory On Hand
SBC / Revenue
1.7%
Capex / Revenue
6.2%
Working Capital
$-94M
Net Current Asset Value
$-766M
Invested Capital
$378M
OCF / Net Income
-3.75
FCF / Net Income
-2.15
Accruals Ratio (Sloan)
-14.4%
Net Debt
$406M
Net Debt / EBITDA
3.75
Interest Coverage
Cash Coverage
Capex Coverage
2.34
Tangible Common Equity
$-362M
TCE / Total Assets
-36.9%
Goodwill / Total Assets
6.2%
NOPAT
$36M
Cash ROIC
17.0%
WC / Revenue
-12.2%
Capex / D&A
0.76
Reinvestment Rate
9.8%
Total Payout Ratio
Asset Growth vs Revenue Growth
-7.8%
Revenue 5Y CAGR
56.4%
EPS 5Y CAGR
FCF 5Y CAGR
EBITDA 5Y CAGR
4.7%
Book Value 5Y CAGR
Stock Price (FY-end)
$14
Market Cap
$793M
P/E Ratio
P/S Ratio
1.03
P/B Ratio
P/TB Ratio
P/OCF Ratio
7.10
P/FCF Ratio
12.42
Enterprise Value
$1.20B
EV / EBITDA
11.07
EV / Sales
1.55
EV / FCF
18.78
FCF Yield
8.1%
Shareholder Yield
-1.7%
Capex Yield
6.0%
Operating Leverage
5.67
Graham Number
Shares Variation (YoY)
2.1%
Beta (5Y)
1.72
Cost of Equity
13.1%
Cost of Debt (after tax)
52W High
$15
52W Low
$8
Trailing Return 1Y
20.1%
Trailing Return 5Y
-7.0%
F-Score (Piotroski)
7.00
Z-Score (Altman)
0.66

Earnings Forecasts

Per-quarter consensus estimates + actuals + beat/miss surprise. Sourced from Finnhub (Wall Street consensus aggregation).

Source caveat: Finnhub free tier returns the consensus mean only — analyst high / low / dispersion + analyst counts require a paid plan. A "$5.00 consensus" line above could mean "20 analysts at exactly $5" (high conviction) or "10 at $5.50, 10 at $4.50" (split). Treat single-line consensus accordingly.

EPS — Consensus vs Actual

Revenue — Consensus vs Actual

Beat / Miss vs Estimate

Stock Price on Earnings Dates

LINDBLAD EXPEDITIONS HOLDINGS, INC. — Effective Tax Rate ReconciliationNEW

Bridges from the federal statutory rate (21% post-TCJA) to the effective tax rate via the issuer's tax-note reconciliation lines. Sourced from EffectiveIncomeTaxRateReconciliation* flat CompanyFacts concepts. Conditional lines (R&D credits, FDII, SBC, valuation allowance, etc.) only render when the issuer discloses them. Persistent divergence between accrual tax expense and cash taxes paid is a leading signal for deferred-tax buildup.

Effective Rate Trend

Reconciliation LineFY2020FY2021FY2022FY2023FY2024FY2025
Federal Statutory Rate21.00%21.00%21.00%21.00%21.00%21.00%
State & Local Income Taxes0.40%-0.80%-0.30%-2.10%-1.40%-0.50%
Foreign Rate Differential-10.50%-15.20%-16.60%-17.10%-32.70%
Other Adjustments0.20%0.80%-0.70%0.70%-1.30%-0.70%
SBC (Nondeductible)0.00%
Nondeductible Expenses-0.10%
Valuation Allowance Change-2.20%-4.10%-9.40%-6.80%7.20%-6.50%
Tax Law Change0.00%0.00%4.60%
Effective Tax Rate8.90%1.70%-6.00%-8.30%-12.40%-11.40%

Cash vs Accrual

ItemFY2020FY2021FY2022FY2023FY2024FY2025
Income Tax Expense (Accrual)−$9.8M−$2.0M$6.1M$3.1M$3.1M$2.5M
Income Taxes Paid (Cash)$700.0K$98.0K$309.0K$711.0K$319.0K$3.2M

LINDBLAD EXPEDITIONS HOLDINGS, INC. — M&A AcquisitionsNEW

Per-deal acquisition disclosures sourced from us-gaap:BusinessAcquisitionAxis dimensional XBRL. Each card surfaces the deal's purchase-price allocation (goodwill vs intangibles vs liabilities), contingent consideration (unpaid earn-outs), and pro-forma combined-entity numbers. Probability-of-Success (PoS) factor on biotech targets is the ASC 805 contingent-consideration valuation — higher = closer to commercialization, higher implied target value.

Winelandthomson Adventures Inc

Total Consideration

$30.0M

Purchase-Price Allocation

Goodwill

$17.0M

Intangibles

$8.6M

Torcatt Enterprises Limitada

Purchase-Price Allocation

Intangibles

$3.3M